Survey results suggest that chronic myeloid leukaemia (CML) patients using tyrosine kinase inhibitor (TKI) therapy have good adherence to treatment but might benefit from counselling regarding their ...
BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Teacher and CML patient Jen joins Dr. James Dugan to share how finding the right treatment changed her life—and what other patients need to know.
Patients with chronic myeloid leukemia (CML) who are being treated with tyrosine kinase inhibitors (TKIs) have significant adverse effects and quality-of-life issues that need to be addressed, ...
NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a ...
Hosted on MSN
Living with chronic myeloid leukaemia: Najha’s story
KUALA LUMPUR: For many, chronic myeloid leukaemia (CML) is an unfamiliar term. It is a type of blood cancer that begins in the bone marrow and affects white blood cells. While not as common as other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback